Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 23;24(4):96.
doi: 10.31083/j.rcm2404096. eCollection 2023 Apr.

Role of LncRNAs in the Pathogenesis of Coronary Artery Disease

Xinyu Wu  1 , Jingru Li  1 , Guihu Sun  1 , Jun Yang  1 , Yunzhu Peng  1 , Xiangfeng Bai  2 , Luqiao Wang  1
Affiliations
Review

Role of LncRNAs in the Pathogenesis of Coronary Artery Disease

Xinyu Wu et al. Rev Cardiovasc Med. .

Abstract

Coronary artery disease (CAD), caused by coronary artery occlusion, is a common cardiovascular disease worldwide. Long non-coding RNAs (lncRNAs) are implicated in the regulation of endothelial cell injury, angiogenesis, plaque formation, and other pathological mechanisms in CAD by acting on different cell types. Some lncRNAs are significantly upregulated in CAD patients; however, other lncRNAs are significantly downregulated. Differential expression of lncRNAs in CAD patients enables them to be exploited as potential biomarkers to evaluate disease progression and diagnosis/prognosis in CAD patients. In this study, we reviewed the role of lncRNAs in the development of different clinical subtypes of CAD.

Keywords: cardiac fibroblasts; cardiomyocytes; coronary artery disease; diagnostic biomarkers; endothelial cells; lncRNA; vascular smooth muscle cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
LncRNAs as biomarkers of CAD participate in pathological processes and then affect the occurrence and development of CAD. Abbreviations: ECs, endothelial cells; VSMCs, vascular smooth muscle cells; CM, cardiomyocyte; CF, cardiac fibrosis.
See this image and copyright information in PMC

References

    1. Amin AM. Metabolomics applications in coronary artery disease personalized medicine. Advances in Clinical Chemistry . 2021;102:233–270. - PubMed
    1. Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduction and Targeted Therapy . 2022;7:78. - PMC - PubMed
    1. Davies MJ, Fulton WF, Robertson WB. The relation of coronary thrombosis to ischaemic myocardial necrosis. The Journal of Pathology . 1979;127:99–110. - PubMed
    1. Davies MJ, Thomas AC. Plaque fissuring–the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. British Heart Journal . 1985;53:363–373. - PMC - PubMed
    1. Berezin AE, Berezin AA. Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers. Disease Markers . 2020;2020:1215802. - PMC - PubMed

LinkOut - more resources